Serialisation Shifts From Compliance to Live Operational Control

Why It Matters

By turning traceability data into live decision tools, pharma air freight can protect product integrity, cut costly disruptions, and sustain growing demand for temperature‑sensitive biologics.

Key Takeaways

• EPCIS 2.0 enables real‑time data exchange across air freight hubs
• Live sensor data allows temperature deviations to be corrected mid‑flight
• AI and digital twins simulate routing to pre‑empt cold‑chain failures
• QR and NFC verification feed shipment status back to manufacturers
• Early exception detection narrows recalls to individual packs, preserving capacity

Pulse Analysis

The pharmaceutical air‑freight sector has long relied on serialisation to satisfy regulatory mandates such as the EU Falsified Medicines Directive. At this year’s LogiPharma conference in Vienna, industry executives highlighted a decisive pivot: serialisation data is now being harnessed for real‑time operational control. The rollout of EPCIS 2.0, with its faster event‑data exchange and standardized messaging, allows carriers to share temperature, location and status updates instantly across multiple hubs. This connectivity transforms a once‑static compliance record into a dynamic decision‑making engine.

Connected sensors and continuous monitoring are the linchpins of that transformation. Modern IoT tags transmit temperature and humidity readings while a shipment is in flight, enabling ground crews to reroute or prioritize unloading the moment a deviation occurs. Artificial intelligence and digital‑twin models ingest this stream to predict stress points and suggest alternative routing before a breach materialises. Complementary QR and NFC packaging not only verify authenticity but also feed scan data back to manufacturers, creating a closed‑loop feedback system that sharpens exception management across the supply chain.

The business payoff is immediate. Early detection narrows recalls to individual packs rather than whole pallets, preserving valuable uplift capacity on congested aircraft and reducing quarantine expenses. For vaccine and biologic distributors, where a few degrees can render product unusable, live intervention safeguards revenue and patient access. As airlines allocate more belly‑hold space to high‑value pharma cargo, the ability to guarantee cold‑chain integrity through proactive, data‑driven actions will become a competitive differentiator, driving further investment in serialisation‑enabled operational platforms.